ARTICLE
8 December 2009

Proposed New Canadian Product Safety Law Aims To Raise Safety Standards

TL
Torys LLP

Contributor

Torys LLP is a respected international business law firm with a reputation for quality, innovation and teamwork. Our experience, our collaborative practice style, and the insight and imagination we bring to our work have made us our clients' choice for their largest and most complex transactions as well as for general matters in which strategic advice is key.
Bill C-6, the Canada Consumer Product Safety Act (CCPSA), aims to strengthen Canadian consumer product safety law by establishing a broad prohibition against manufacturing, importing, advertising or selling consumer products that pose an unreasonable danger to human health or safety.
Canada Consumer Protection

Bill C-6, the Canada Consumer Product Safety Act (CCPSA), aims to strengthen Canadian consumer product safety law by establishing a broad prohibition against manufacturing, importing, advertising or selling consumer products that pose an unreasonable danger to human health or safety.1 The bill, which was first discussed in Torys' May 2008 Food and Drug Regulatory Bulletin, was recently considered by the Senate Standing Committee on Social Affairs, Science and Technology.

Key features of the CCPSA:

  • It empowers the Minister of Health to order manufacturers and importers to conduct product testing and to share test results and other information with the Minister;
  • It requires industry to prepare and maintain documents to facilitate product tracing;
  • It creates mandatory reporting obligations for manufacturers, importers and sellers who know about a serious incident or death resulting from a consumer product;
  • It empowers the Minister to disclose confidential business information to certain government authorities, without consent or notice, if there is a serious or imminent danger to human health or safety;
  • It provides inspectors with broad powers, including the authority to enter premises, to seize and detain products and to order a product recall if there are reasonable grounds to believe that the product poses a danger to human health or safety; and
  • It provides significant fines and penalties for violating the CCPSA.

The Committee made several amendments to the bill after considering the constitutionality of its search and seizure provisions. As a result of the amendments, the bill must be returned to the House of Commons for a vote, which could delay its passage.

For further information, please see
http://www.hc-sc.gc.ca/cps-spc/legislation/acts-lois/bill_c6-loi-eng.php.

Footnotes

1.The CCPSA does not apply to natural health products, food, drugs, cosmetics or medical devices.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More